期刊文献+

蛋白组学技术分析不同转移潜能结肠癌细胞株差异表达蛋白 被引量:2

Screening differential protein expressions in colorectal carcinoma cell lines with varying metastatic potentials using proteomic analysis method
下载PDF
导出
摘要 目的:应用蛋白质组学技术分析具有不同转移潜能的人结肠癌LoVo和SW480细胞之间差异表达的蛋白,以寻找结肠癌转移早期诊断生物标志物。方法:应用双向凝胶电泳分离具有高转移潜能的LoVo细胞和低转移潜能的SW480细胞的总蛋白质,凝胶银染和考马斯亮蓝染色,建立双向凝胶电泳图谱,经Image Master软件进行图像分析,筛选部分分离较好的差异蛋白质点。应用基质辅助激光解析电离飞行时间质谱(MALDI-TOF)分析部分差异表达的蛋白质点,获取肽质量指纹图谱,Mascot软件搜索NCBInr数据库鉴定蛋白质。结果:筛选出21个差异蛋白质点,成功鉴定出5种差异蛋白质,其中在LoVo细胞株中表达上调的蛋白有埃兹蛋白(Ezrin)、转录延长因子A(transcription elongation factor A)和甘氨酸A/C(lamin A/C),在SW480细胞株中表达上调的蛋白有NM23蛋白[non-metastatic cells 1,protein (NM23A) expressed in isoform a]和(heat shockprotein 8,热休克蛋白8)。结论:研究发现,这些差异蛋白质的功能涉及肿瘤细胞生长、运动、黏附和凋亡等过程,研究结果为寻找结直肠癌转移早期诊断生物标志物提供了理论依据。 Objective: To analyze the differential protein expressions in highly-metastatic eolorectal carcinoma cell lines LoVo and low-metastatic SW480 cells using proteomic analysis method and detect the biological molecule for early diagnosis of metastasis of colo-rectal carcinoma. Methods:Proteins in highly-metastatic LoVo cells and low-metastatic SW480 cells were isolated by two-dimension gel electrophoresis(Two -DE). Two-DE map was established by gel-silver staining and Coomassie brilliant blue staining. The well differentially expressed protein spots were screened by Image Master imaging. The specific protein spots were identified by peptide mass fingerprints using matrix-assisted laser desorption/time of flight mass spectrometry ( MALDI-TOF/MS ) and through searching NCBInr database using Mascot software. Results:Twenty one differential protein spots were screened and 5 differential proteins were identified. They included Ezrin protein, transcription elongation factor A, and lamin A/C which were up-regulated in LoVo cells and non-metastatic protein expressed in isoform a (NM23A) and heat shock protein 8 (HSPA8) which were up-regulated in SW480 cells. Conclusion: This study has found that the differential proteins are related with tumor growth, migration, adhesion and apoptosis. Our results provide theoretical basis for finding biological markers for early diagnosis of metastasis of eolorectal carcinoma.
作者 黄龙 秦环龙
出处 《肿瘤》 CAS CSCD 北大核心 2008年第11期925-928,共4页 Tumor
基金 上海市科委基金资助项目(编号:05DJ14010)
关键词 结直肠肿瘤 蛋白质组学 电泳 凝胶 双向 Colorectal neoplasms Proteomics Electrophoresis,gel, two-dimensional
  • 相关文献

参考文献14

  • 1KIVELA T,JAASKELAINEN J,VAHERI A, et al. Ezrin ,a membrane-organizing protein , as a polarization marker of the retinal pigment epithelium invertebrates [ J ]. Cell Tissue Res, 2000,301 (2) :217-223.
  • 2MARTIN T A, HARRISON G, MANSEL R F, et al. The role of the CD44/Ezrin complex in cancer metastasis[ J]. Crit Rev Oncol Hematol,2003,46 ( 2 ) : 165-186.
  • 3YEH T S,TSENG J H, LIU N J, et al. Significance of cellular distribution of Ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma[ J ]. Arch Surg,2005,40 ( 12 ) :1184-1190.
  • 4ZENG H,XU L,XIAO D, et al. Altered expression of ezrin in esophageal squamous cell carcinoma [ J ]. Histochem Cytochem, 2006,54( 8 ) :889-896.
  • 5KHANNA C, WAN X, BOSE S, et al. The memrance-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis [ J ]. Nat Med,2004 ,10( 6 ) :182-186.
  • 6YU Y, KHAN J, KHANNA C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six21 as key metastatic regulators [ J ]. Nat Med, 2004,10 (2) :175-181.
  • 7PUJUGUET P, DEL MAESTRO L, GAUTREAU A, et al. Ezrin regulates E-cadherin-dependent adherens junction assembly through Racl activation [ J ]. Mol Biol Cell, 2003,14 ( 5 ) : 2181 - 2191.
  • 8STAPLETON G, MALLIRI A, OZANNE B W. Downregulated AP21 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells[J]. Cell Sci,2002,115(13) :2713-2724.
  • 9KESHAMOUNI V G, MICHAILIDIS G, GRASSO CS, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of tung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype [ J ]. Proteome Res, 2006,5 (5) :1143-1154.
  • 10YU Y, DAVICIONI E, TRICHE T J, et al. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis [ J ]. Cancer Res, 2006,66 (4) :1982-1989.

同被引文献21

  • 1CARR K M, ROSENBLATr K, PETRICOIN E F, et al. Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy [ J ]. Hunt Genomics, 2004, 1 ( 2 ) : 134-140.
  • 2PEI H, ZHU H, ZENG S, et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer[ J ]. J Proteome Res, 2007, 6 (7) : 2495-2501.
  • 3STIERUM R, GASPARI M, DOMMELS Y, et al. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the coloreetal cancer cell line Caco-2 [ J ]. Biochim Biophys Acta, 2003,1650(1/2) :73-91.
  • 4STULIK J, HEMYCHOVA L, PORKERTOVA S ,et al. Proteome study of colorectal cancinogenesis [ J ]. Electrophoresis, 2001,22 (14) :3019-3025.
  • 5YOSHIKAWA R, YANAGI H, HASHIMOTO-TAMAOKI T, et al. Gene expression in response to anti-tumour intervention by polysaecharide-K (PSK) in colorectal carcinoma cells [ J].Olwol Rep J, 2004, 12(6) :1287-1293.
  • 6SOHN K J, SM1RNAKIS F, MOSKOVITZ D N, et al. Effects of folylpolyglutamate synthetase modulalion on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate [ J]. Gut, 2004, 53(12) :1825-1831.
  • 7DONG Y B, YANG H L, MCMASTERS K M. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin[ J ]. Cancer Gerte Ther, 2003 , 10(3) :168-178.
  • 8GOUVERIS P, LAZARIS A C, PAPATHOMAS T G, et al. Topoisomerase I protein expression in primary colorectal cancer and recurrences after 5-FU-based adjuvant chemotherapy[ J]. J Cancer Res Clin Oncol, 2007 ,133(12) :1011-1015.
  • 9KWON W S, RHA S Y, CHOI Y H, et al. Ribonucleotide reductase M1 ( RRM1 ) 2 464G > A polymovphism shows an association with gemcitabine chemosensitivity in cancer cell lines [ J]. Pharmacogenet Genomics, 2006 , 16 ( 6 ) :429-438.
  • 10BERGMAN A M, EIJK P P, RUIZ VAN HAPEREN V W, et al. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant [ J ]. Cancer Res, 2005, 65 (20) :9510-6.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部